Concourse Financial Group Securities’s Cadrenal Therapeutics CVKD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Hold
0
1792
2024
Q4
Hold
0
3584
2024
Q3
Hold
0
3579
2024
Q2
Hold
0
3626
2024
Q1
Hold
0
3640
2023
Q4
Hold
0
3578
2023
Q3
Hold
0
3560
2023
Q2
Hold
0
3533